🔥Telegram İfşa

New content online! Biologic choice matters in PsA prevention dlvr.it/SlRRfT

ICYMI: Patients with #psoriasis treated with interleukin-12/23 or IL-23 inhibitors may be less likely to progress to inflammatory #arthritis than those treated with TNF inhibitors #RheumTwitter Medical College of Wisconsin bit.ly/41uf1xl

New article! The Use and Availability of #Ultrasound for #PsoriaticArthritis among #GRAPPA Members Lihi Eder Shikha Singla, MD #DrGurjitKaeley pubmed.ncbi.nlm.nih.gov/37419859/ The survey identified 3 major barriers: 1⃣lack of time,2⃣ training, and 3⃣cost of the machine.

Psoriasis for Rheumatologists Watch experts Dr. Saakshi Khattri and Dr. Shikha Singla discuss what rheumatologists can learn from psoriasis trials in this therapeutic update sponsored by AbbVie US Medical Affairs. bit.ly/3sjaoKp

It is paramount to have a unified definition of difficult-to-treat PsA to provide guidance for clinicians and researchers

📢 PsA is a complex disorder where only 23.1% of PsA patients achieve remission. Factors like disease activity, comorbidities, and treatment accessibility contribute. So, we need to better understand D2T-PsA. New publication by the GRAPPA project of D2T/C2M-PsA 🧵 🔗👇

Paradoxical psoriasis with IL-17 inhibitors academic.oup.com/rheumap/articl… Dimitri Luiz

Ongoing efforts aim to differentiate biologically refractory cases from cases with comorbid conditions and social factors that can contribute to treatment nonre… Source: Medscape search.app/quWPNusB8H3M1j…

Sequencing of Targeted Therapy in Psoriasis: Does it Matter? | American Journal of Clinical Dermatology link.springer.com/article/10.100…

MACE Risk Similar Across Biologic Classes Used to Treat Psoriasis, Psoriatic Arthritis medscape.com/viewarticle/ma… medscape.com/viewarticle/ma… Mike Putman Rheum Cat

Don't forget to register for the the upcoming SPARTAN-GRAPPA-ASAS Symposium next month! This event is open for registration now and promises to be an incredible opportunity to explore research and insights on spondyloarthritis and psoriatic disease. Don’t miss out—secure your

📢 Live from the SPARTAN-GRAPPA-ASAS Educational Symposium at #ACR2024! Dr. Shikha Singla shared key insights on how biological sex influences the response to advanced therapies in PsA, with effects varying by drug class. Key takeaways: ✔️ Sex differences matter in treatment

The #IPC symposium at #AAD2025, Preventing Comorbid Disease in Psoriasis, is today at 2:00 PM EST in Orange County Convention Center, Room W204ABC, Level 2, West Concourse. Thank you to @AbbVie for supporting this symposium! psoriasiscouncil.org/event-post/aad… #IPCEvent #IPCSymposium

Had d privilege of hosting Dr. Shikha Singla from University of Wisconsin & Director of PsA program! She delivered an insightful lecture on "Difficult to treat PsA," engaging with residents & offering invaluable opinions on our cases.A truly enriching experience!

Higher Rates of Psoriatic Arthritis in Patients with Calcium Pyrophosphate Deposition Disease than in Controls: A Retrospective Cohort Study mdpi.com/2813-4583/3/2/5

⚠️ What makes PsA difficult to treat? Our new GRAPPA-led study asked 570 patients in 10 languages 🌍 🗣️ Findings? Fatigue, persistent pain, and life impact go far beyond what labs can show. 🔗 academic.oup.com/rheumatology/a… #D2T #PsA GRAPPA Network - Official Dr. Fabian Proft

Secular trends in biologic prescribing for psoriasis and psoriatic arthritis, 2014‐2024 - Mirza - Arthritis & Rheumatology - Wiley Online Library ⁦Rheum Cat⁩ ⁦Mike Putman⁩ acrjournals.onlinelibrary.wiley.com/doi/10.1002/ar…

🎙️ New Inside GRAPPA Episode! Defining Difficult-to-Treat and Complex-to-Manage Psoriatic Arthritis What truly makes a PsA case difficult to treat or complex to manage? In this compelling episode, host Dr. Hanna Johnsson dives into this crucial question with GRAPPA experts: 🔹

🌍 How do global guidelines tackle PsA? New review compares ACR, EULAR, BSR, GRAPPA & PANLAR: 📌 All agree: Treat-to-target 🔄 Differences in: • Biologic/tsDMARD sequencing • Enthesitis & dactylitis management • Comorbidity integration 🔍 Read&RT journals.lww.com/jclinrheum/abs…

Biologic Sequence for the Treatment of Psoriatic Arthritis Following Nonresponse: A Narrative Review | Dermatology and Therapy link.springer.com/article/10.100…